Hydroxychloroquine enhances efferocytosis and modulates inflammation via MerTK/Gas6 signaling in a pristane-induced lupus mouse model
{{output}}
Background: Hydroxychloroquine (HCQ) is a frontline treatment for autoimmune diseases, including rheumatoid arthritis, Sjogren's syndrome, and systemic lupus erythematosus (SLE), due to its potent immunomodulatory properties. Ef... ...
